Sign In
Buy ANIX
$2.52
-0.0300 (-1.18%)
At Close: Jun 03, 2026
Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
08:30am, Monday, 27'th Nov 2023
SAN JOSE, Calif. , Nov. 27, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
FATE Q3 Earnings Beat on Lower Expenses, Revenues Fall Y/Y
11:02am, Thursday, 09'th Nov 2023
FATE reports better-than-expected third-quarter 2023 financial results, driven by lower operating expenses. The stock rises about 5% in the after-market hours.
Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
08:30am, Tuesday, 31'st Oct 2023
Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial SAN JOSE, Calif. , Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnolog
SAN JOSE, Calif. , Oct. 23, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Bears are Losing Control Over ANIXA BIOSCIENCES INC (ANIX), Here's Why It's a 'Buy' Now
11:16am, Friday, 13'th Oct 2023
ANIXA BIOSCIENCES INC (ANIX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreemen
Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
08:30am, Friday, 13'th Oct 2023
- With no dose-limiting toxicities observed, treatment of second dose cohort to begin SAN JOSE, Calif. , Oct. 13, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX
ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?
01:32pm, Thursday, 21'st Sep 2023
ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The 3 Most Undervalued Cheap Stocks to Buy in September 2023
10:11pm, Monday, 11'th Sep 2023
The United States Treasury Secretary, Janet Yellen, recently expressed her confidence in the economy's ability to recover from the recession without causing significant harm to the job market or spark
What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock
01:21pm, Thursday, 22'nd Jun 2023
ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?
11:32am, Tuesday, 25'th Apr 2023
Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine
07:13pm, Tuesday, 18'th Apr 2023
Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine
Anixa (ANIX) Falls 25% Despite Positive Breast Cancer Study Data
12:55pm, Tuesday, 18'th Apr 2023
Anixa Biosciences (ANIX) announces positive top-line data from its phase Ia study evaluating the safety of its breast cancer vaccine. However, the stock plunges 25% in the absence of efficacy reports.
What Makes ANIXA BIOSCIENCES INC (ANIX) a Good Fit for "Trend Investing"
10:32am, Friday, 28'th Oct 2022
ANIXA BIOSCIENCES INC (ANIX) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conference
08:30am, Wednesday, 31'st Aug 2022
SAN JOSE, Calif. , Aug. 31, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announ
Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times
01:38pm, Wednesday, 11'th May 2022
Anixa Biosciences has different very interesting programs ongoing, one of which is a breast cancer vaccine trial with a first partial readout at ASCO in the beginning of June. While the biotech sector
